OBJECTIVES: In a large cohort of subjects undergoing total pancreatectomy with islet autotransplantation (TPIAT), we assessed the prevalence and duration of gastrointestinal (GI) symptoms before and after the procedure to determine the impact of enzyme adherence on GI symptoms. METHODS: Three hundred fifty-six preoperative and postoperative questionnaires were collected from 184 subjects between ages of 5 and 66 years who underwent TPIAT between 2008 and 2011 at the University of Minnesota. Questionnaires were analyzed for self-reported frequency and severity of GI symptoms, pancreatic enzyme usage, and glycemic variability index (GVI). RESULTS: After surgery, patient-reported steatorrhea increased whereas constipation decreased. Gastrointestinal symptoms interfered with daily activity in 44% to 69% of subjects, before and after surgery, despite high reported enzyme adherence. Postoperatively, more than 79% of subjects reported consistent use of enzymes at all meals. Presence of GI symptoms did not vary with adherence. The GVI of 2 had a 2.8-fold increased odds of steatorrhea (95% confidence interval, 1.1-7.0) compared with GVI of 0. CONCLUSIONS: Gastrointestinal symptoms were common after TPIAT; ongoing management is needed. Enzyme nonadherence was not a major contributor to diarrhea/steatorrhea in this cohort. Glycemic variability was closely associated with steatorrhea; poor response to enzyme replacement may complicate diabetes management.
OBJECTIVES: In a large cohort of subjects undergoing total pancreatectomy with islet autotransplantation (TPIAT), we assessed the prevalence and duration of gastrointestinal (GI) symptoms before and after the procedure to determine the impact of enzyme adherence on GI symptoms. METHODS: Three hundred fifty-six preoperative and postoperative questionnaires were collected from 184 subjects between ages of 5 and 66 years who underwent TPIAT between 2008 and 2011 at the University of Minnesota. Questionnaires were analyzed for self-reported frequency and severity of GI symptoms, pancreatic enzyme usage, and glycemic variability index (GVI). RESULTS: After surgery, patient-reported steatorrhea increased whereas constipation decreased. Gastrointestinal symptoms interfered with daily activity in 44% to 69% of subjects, before and after surgery, despite high reported enzyme adherence. Postoperatively, more than 79% of subjects reported consistent use of enzymes at all meals. Presence of GI symptoms did not vary with adherence. The GVI of 2 had a 2.8-fold increased odds of steatorrhea (95% confidence interval, 1.1-7.0) compared with GVI of 0. CONCLUSIONS:Gastrointestinal symptoms were common after TPIAT; ongoing management is needed. Enzyme nonadherence was not a major contributor to diarrhea/steatorrhea in this cohort. Glycemic variability was closely associated with steatorrhea; poor response to enzyme replacement may complicate diabetes management.
Authors: David E R Sutherland; David M Radosevich; Melena D Bellin; Bernard J Hering; Gregory J Beilman; Ty B Dunn; Srinath Chinnakotla; Selwyn M Vickers; Barbara Bland; A N Balamurugan; Martin L Freeman; Timothy L Pruett Journal: J Am Coll Surg Date: 2012-03-06 Impact factor: 6.113
Authors: Melena D Bellin; Martin L Freeman; Sarah Jane Schwarzenberg; Ty B Dunn; Gregory J Beilman; Selwyn M Vickers; Srinath Chinnakotla; A N Balamurugan; Bernhard J Hering; David M Radosevich; Antoinette Moran; David E R Sutherland Journal: Clin Gastroenterol Hepatol Date: 2011-05-05 Impact factor: 11.382
Authors: Susan S Baker; Drucy Borowitz; Linda Duffy; Laura Fitzpatrick; Joyce Gyamfi; Robert D Baker Journal: J Pediatr Date: 2005-02 Impact factor: 4.406
Authors: Markus Wehler; Ralf Nichterlein; Bernhard Fischer; Michael Farnbacher; Udo Reulbach; Eckhart Georg Hahn; Thomas Schneider Journal: Am J Gastroenterol Date: 2004-01 Impact factor: 10.864
Authors: O Pieramico; J E Dominguez-Muñoz; D K Nelson; W Böck; M Büchler; P Malfertheiner Journal: Gastroenterology Date: 1995-07 Impact factor: 22.682
Authors: A Carroccio; F Pardo; G Montalto; L Iapichino; M Soresi; M R Averna; G Iacono; A Notarbartolo Journal: Dig Dis Sci Date: 1992-09 Impact factor: 3.199
Authors: George K John; Vikesh K Singh; Robert A Moran; Daniel Warren; Zhaoli Sun; Niraj Desai; Christi Walsh; Rita R Kalyani; Erica Hall; Kenzo Hirose; Martin A Makary; Ellen M Stein Journal: J Gastrointest Surg Date: 2017-01-12 Impact factor: 3.452
Authors: Melena D Bellin; Sarah J Schwarzenberg; Marie Cook; David E R Sutherland; Srinath Chinnakotla Journal: Curr Diab Rep Date: 2015-10 Impact factor: 4.810
Authors: Daniel J Kilburn; Adrian K H Chiow; Universe Leung; Mehan Siriwardhane; David J Cavallucci; Richard Bryant; Nicholas A O'Rourke Journal: J Gastrointest Surg Date: 2016-12-26 Impact factor: 3.452
Authors: Jillian K Wothe; Robert Aidoo; Kendall R McEachron; Tasma Harindhanavudhi; Guru Trikudanathan; Martin L Freeman; Varvara Kirchner; Timothy L Pruett; Gregory J Beilman; James S Hodges; Melena D Bellin Journal: Pancreatology Date: 2021-09-04 Impact factor: 3.996
Authors: Varvara A Kirchner; Ty B Dunn; Gregory J Beilman; Srinath Chinnakotla; Timothy L Pruett; Joshua J Wilhelm; Sarah J Schwarzenberg; Martin L Freeman; Melena D Bellin Journal: Curr Treat Options Gastroenterol Date: 2017-12